INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
INFU gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. INFU scores excellent on profitability, but there are some minor concerns on its financial health. INFU is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
INFU had positive earnings in the past year.
In the past year INFU had a positive cash flow from operations.
INFU had positive earnings in each of the past 5 years.
Each year in the past 5 years INFU had a positive operating cash flow.
1.2 Ratios
INFU's Return On Assets of 3.06% is fine compared to the rest of the industry. INFU outperforms 65.05% of its industry peers.
The Return On Equity of INFU (5.78%) is better than 63.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.47%, INFU is in the better half of the industry, outperforming 72.82% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INFU is significantly below the industry average of 9.71%.
The last Return On Invested Capital (7.47%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROIC | 7.47% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
Looking at the Profit Margin, with a value of 2.32%, INFU is in the better half of the industry, outperforming 63.11% of the companies in the same industry.
INFU's Profit Margin has been stable in the last couple of years.
INFU's Operating Margin of 6.07% is fine compared to the rest of the industry. INFU outperforms 64.08% of its industry peers.
INFU's Operating Margin has improved in the last couple of years.
INFU's Gross Margin of 53.13% is fine compared to the rest of the industry. INFU outperforms 76.70% of its industry peers.
In the last couple of years the Gross Margin of INFU has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INFU is destroying value.
Compared to 1 year ago, INFU has more shares outstanding
Compared to 5 years ago, INFU has more shares outstanding
The debt/assets ratio for INFU has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.53 indicates that INFU is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.53, INFU is in line with its industry, outperforming 57.28% of the companies in the same industry.
The Debt to FCF ratio of INFU is 12.54, which is on the high side as it means it would take INFU, 12.54 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 12.54, INFU perfoms like the industry average, outperforming 44.66% of the companies in the same industry.
INFU has a Debt/Equity ratio of 0.52. This is a neutral value indicating INFU is somewhat dependend on debt financing.
INFU has a Debt to Equity ratio of 0.52. This is comparable to the rest of the industry: INFU outperforms 59.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Altman-Z | 2.53 |
ROIC/WACC0.81
WACC9.18%
2.3 Liquidity
INFU has a Current Ratio of 2.21. This indicates that INFU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.21, INFU is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that INFU should not have too much problems paying its short term obligations.
INFU's Quick ratio of 1.83 is fine compared to the rest of the industry. INFU outperforms 68.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 6900.00% over the past year.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
The Revenue has been growing slightly by 7.98% in the past year.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
3.2 Future
Based on estimates for the next years, INFU will show a very strong growth in Earnings Per Share. The EPS will grow by 84.76% on average per year.
The Revenue is expected to grow by 8.03% on average over the next years. This is quite good.
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 42.93, which means the current valuation is very expensive for INFU.
INFU's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.05, INFU is valued quite expensively.
INFU is valuated rather expensively with a Price/Forward Earnings ratio of 17.61.
Based on the Price/Forward Earnings ratio, INFU is valued a bit cheaper than the industry average as 65.05% of the companies are valued more expensively.
INFU is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.93 | ||
| Fwd PE | 17.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INFU is valued cheaper than 83.50% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as INFU.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.09 | ||
| EV/EBITDA | 7.21 |
4.3 Compensation for Growth
INFU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 84.76% in the coming years.
PEG (NY)0.54
PEG (5Y)4.06
EPS Next 2Y84.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
INFU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:INFU (7/25/2025, 8:04:00 PM)
6.01
+0.1 (+1.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.54%
Inst Owner Change0.32%
Ins Owners4.42%
Ins Owner Change0.69%
Market Cap126.09M
Analysts84
Price Target13.9 (131.28%)
Short Float %0.81%
Short Ratio0.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-48.06%
Max EPS beat(2)75.49%
EPS beat(4)2
Avg EPS beat(4)7.91%
Min EPS beat(4)-48.06%
Max EPS beat(4)75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-4.92%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)0%
PT rev (3m)-3.54%
EPS NQ rev (1m)-21.05%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.93 | ||
| Fwd PE | 17.61 | ||
| P/S | 0.92 | ||
| P/FCF | 55.09 | ||
| P/OCF | 5.77 | ||
| P/B | 2.29 | ||
| P/tB | 2.79 | ||
| EV/EBITDA | 7.21 |
EPS(TTM)0.14
EY2.33%
EPS(NY)0.34
Fwd EY5.68%
FCF(TTM)0.11
FCFY1.82%
OCF(TTM)1.04
OCFY17.34%
SpS6.56
BVpS2.63
TBVpS2.16
PEG (NY)0.54
PEG (5Y)4.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROCE | 9.46% | ||
| ROIC | 7.47% | ||
| ROICexc | 7.6% | ||
| ROICexgc | 8.58% | ||
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% | ||
| FCFM | 1.66% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Debt/EBITDA | 1.35 | ||
| Cap/Depr | 151.51% | ||
| Cap/Sales | 14.23% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.77% | ||
| Profit Quality | 71.76% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.53 |
F-Score9
WACC9.18%
ROIC/WACC0.81
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y149.37%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.23%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y64.52%
OCF growth 3Y3.76%
OCF growth 5Y8.08%